ELENA BARCELO: Open Payments
NPI 1033820097 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 77 payments from 15 companies in 2025. Trend: 2023 $1,383 · 2024 $1,021 · 2025 $1,970
Food & beverage: $1,970
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $361 |
| Neurocrine BioSciences, Inc. | 8 | $234 |
| ABBVIE INC. | 11 | $191 |
| E.R. Squibb & Sons, L.L.C. | 3 | $175 |
| Axsome Therapeutics, Inc. | 8 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $131 |
| Braeburn Inc. | 6 | $128 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 7 | $122 |
Products named: HETLIOZ, INGREZZA, VRAYLAR, COBENFY, Auvelity, CAPLYTA, BRIXADI, ONPATTRO.
Industry payments across FL — which companies pay providers there.
